Scarica l'app Stockscreener
25.90
2.01%
0.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$25.36
Aprire:
$25.45
Volume 24 ore:
41,582
Relative Volume:
0.10
Capitalizzazione di mercato:
$1.18B
Reddito:
$722.68M
Utile/perdita netta:
$134.71M
Rapporto P/E:
9.7004
EPS:
2.67
Flusso di cassa netto:
$109.94M
1 W Prestazione:
-0.73%
1M Prestazione:
+6.64%
6M Prestazione:
+7.08%
1 anno Prestazione:
-41.93%
Intervallo 1D:
$25.40
$25.83
Intervallo di 1 settimana:
$24.92
$26.57
Portata 52W:
$20.39
$46.43
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Confronta AMPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
25.65 | 1.17B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
118.05 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.27 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.9025 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.14 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.73 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Aggiornamento | Needham | Hold → Buy |
| 2025-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
| 2024-03-05 | Iniziato | JP Morgan | Overweight |
| 2023-11-17 | Iniziato | BofA Securities | Neutral |
| 2023-07-25 | Ripresa | Jefferies | Buy |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-07-29 | Iniziato | CapitalOne | Overweight |
| 2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Iniziato | Northland Capital | Outperform |
| 2019-03-13 | Downgrade | Needham | Buy → Hold |
| 2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-03-13 | Reiterato | Needham | Buy |
| 2017-12-01 | Reiterato | Needham | Buy |
| 2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Reiterato | Needham | Buy |
| 2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-05-10 | Reiterato | Needham | Buy |
| 2016-02-19 | Iniziato | Wells Fargo | Outperform |
| 2015-06-19 | Reiterato | Needham | Buy |
| 2015-06-03 | Iniziato | Raymond James | Strong Buy |
| 2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Will Amphastar Pharmaceuticals Inc. (29A) stock boost dividends furtherJuly 2025 Rallies & Safe Swing Trade Setup Alerts - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock recover faster than industry2025 Geopolitical Influence & Proven Capital Preservation Methods - newser.com
Amphastar Pharmaceuticals : Q3 Financial Results (AMP 2025 Q3 Earnings Release FINAL) - MarketScreener
How Amphastar Pharmaceuticals Inc. stock reacts to oil pricesQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com
Will Amphastar Pharmaceuticals Inc. stock recover faster than marketWeekly Trend Recap & Stock Portfolio Risk Control - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock could be next leaderJuly 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock is listed among top recommendationsJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
How risky is Amphastar Pharmaceuticals Inc. (29A) stock compared to peersWeekly Investment Summary & Technical Pattern Based Signals - newser.com
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder value2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock good for long term investingJuly 2025 Movers & Daily Stock Trend Reports - newser.com
What momentum shifts mean for Amphastar Pharmaceuticals Inc.Bear Alert & AI Powered Buy/Sell Recommendations - newser.com
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.Quarterly Trade Summary & Weekly Chart Analysis and Trade Guides - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock trading at attractive multiplesJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Floyd Petersen Sells 16,679 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat
Campbell & CO Investment Adviser LLC Sells 23,356 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Why Amphastar Pharmaceuticals Inc. stock remains resilientJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Is Amphastar Pharmaceuticals Inc. stock supported by strong cash flowsGap Down & Stock Timing and Entry Methods - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock a buy for dividend portfoliosWeekly Trade Report & High Yield Equity Trading Tips - newser.com
Can Amphastar Pharmaceuticals Inc. stock maintain growth trajectoryWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Amphastar Pharmaceuticals Inc Azioni (AMPH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Petersen Floyd F. | Director |
Nov 13 '25 |
Sale |
26.49 |
16,679 |
441,837 |
75,531 |
0.00%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):